The role of protein kinase Cα in U-87 glioma invasion

International Journal of Developmental Neuroscience

Volumn 17, Issue 5-6, 1999, Pages 447-461

  Cho, Kyung Keun ^a   Mikkelsen, Tom ^a   Lee, Yong J ^b   Jiang, Feng ^a   Chopp, Michael ^a   Rosenblum, Mark L ^a  

^a HENRY FORD HOSPITAL   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Antisense; Glioma; Invasion; Protein kinase C ; Sense; Transfection

Indexed keywords

ISOENZYME; PROTEIN KINASE C;

ARTICLE; CELL INVASION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; COLLAGEN; DNA, ANTISENSE; DNA, COMPLEMENTARY; DRUG COMBINATIONS; GLIOMA; HUMANS; ISOENZYMES; LAMININ; NEOPLASM INVASIVENESS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEOGLYCANS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032825702     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(99)00054-4     Document Type: Article

References (94)

1. Ahmad S., Mineta T., Martuza R.L., Glazer R.I. Antisense expression of protein kinase Cα inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery. 35:1994;904-909.
2. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:1987;3239-3245.
3. Amar A.P., DeArmond S.J., Spencer D.R., Coopersmith P.F., Ramos D.M., Rosenblum M.L. Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion. J. Neurooncol. 20:1994;1-15.
4. Andersson A.M., Moran N., Gaardsvoll H., Linnemann D., Bjerkvig R., Laerum O.D., Bock E. Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells. Int. J. Cancer. 47:1991;124-129.
5. Anton Z., Michael R.F., Jefferey N.B., Darryl C.D., Kevin R.O. Disparity in expression of protein Kinase Cα in human glioma versus glioma derived primary cell line: therapeutic implication. Clin. Cancer Res. 4:1998;1797-1802.
6. Azzi A., Boskoboinik D., Hensey C. The protein kinase C family. Eur. J. Biochem. 208:1992;547-557.
7. Baltuch G., Shenouda G., Langleben A., Villemure J.G. High-dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression. Can. J. Neurol. Sci. 20:1993;168-170.
8. Baltuch G.H., Dooley N.P., Couldwell W.T., Yong V.W. Staurosporine differentially inhibits glioma versus nonglioma cell lines. J. Neurooncol. 16:1993;141-147.
9. Baltuch G.H., Dooley N.P., Rostworowski K.M., Villemure J.G., Yong V.W.Z. Protein kinase C isoform a overexpression in C6 glioma cells and its role in cell proliferation. J. Neurooncol. 24:1995;241-250.
10. Baltuch G.H., Dooley N.P., Villemure J.G., Yong V.W. Protein kinase C and growth regulation of malignant gliomas. Can. J. Neurol. Sci. 22:1995;264-271.
11. Baltuch G.H., Couldwell W.T., Villemure J.G., Yong V.W. Protein kinase C inhibitors suppress cell growth in established and lou passage cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery. 33:1993;495-501.
12. Benzil D.L., Finkelstein S.D., Epstein M.H., Finch P.W. Expression pattern of α-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res. 52:1992;2951-2956.
13. Berens M.E., Rutka J.T., Rosenblum M.L. Brain tumor epidemiology growth and invasion. Neurosurg. Clin. North. Am. 1:1990;1-18.
14. Bernstein J.J., Goldberg W.J., Laws E.R. Human malignant astrocytoma xenografts migrate in rat brain. A model for central nervous system cancer research. J. Neurosci. Res. 22:1989;134-143.
15. Berridge M. Inositol trisphosphate and calcium signalling. Nature. 36:1993;315-325.
16. Bjerkvig R., Pedersen P.H., Terzis A.J. Tissue specific invasion of brain tumors. J. Neurooncol. 12 (Abstract):1992;258.
17. Bjerkvig R., Steinsvaag S., Laerum O.D. Reaggregation of fetal rat brain cells in a stationary culture system I: methodology and cell identification. In Vitro. 22:1986;180-192.
18. Bjerkvig R. Reaggregation of fetal rat brain cells in a stationary culture system II: ultrastuctural characterization. In Vitro. 22:1986;193-200.
19. Blobe G.C., Obeid L.M., Hannun Y.A. Regulationof protein kinase C and role in cancer biology. Cancer Metast. Rev. 13:1994;411-431.
20. Borner C., Guadagno S.N., Fabbro D., Weinstein I.B. Expression of four protein kinase C isoforms in rat fibroblasts. J. Biol. Chem. 267:1992;12892-12899.
21. Brandt S.J., Niedel J.E., Bell R.M., Young W.S. Distinct patterns of expression of different protein kinase CmRNAs in rat tissues. Cell. 49:1987;57-63.
22. Burger P.C., Heinz E.R., Shibata T., Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J. Neurosurg. 68:1988;698-704.
23. Cacace A.M., Guadagno S.N., Krauss R.S., Fabbro D., Weinstein I.B. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene. 8:1993;2095-2104.
24. Chambers T.C., Pohl J., Raynor R.L., Kuo J.F. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J. Biol. Chem. 268:1993;4592-4595.
25. Chen C.C. Protein kinase C alpha, delta, epsilon and zeta in C6 glioma cells: TPA induces translocahon and downregulation of conventional and new PKC isoforms but not atypical PKC zeta. FEBS Lett. 332:1993;169-173.
26. Chen G., Manji H.K., Hawver D.B., Wright C.B., Potter W.Z. Chronic sodium valproate selective decreases protein kinase C alpha and epsilon in vitro. J. Neurochem. 63:1994;2361-2364.
27. Choi P.M., Tchou-Wong K.M., Weinstein B. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol. Cell Biol. 10:1990;4650-4657.
28. Clark E.A., Leach K.L., Trojanowski J.Q., Lee V.M. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. Lab. Invest. 64:1991;35-44.
29. Couldwell W.T., Antel J.P., Apuzzo J., Yong V.W. Enhanced protein kinase-C activity determines the growth rate of malignant human gliomas. J. Neurosurg. 74 (Abstract):1991;368.
30. Couldwell W.T., Antel J.P., Apuzzo M.L.J., Yong V.W. Inhibition of growth of established human glioma lines by modulators of the protein kinase-C system. J. Neurosurg. 73:1990;594-600.
31. Couldwell W.T., Antel J.R., Yong V.W. Protein kinase C activity correlates with the growth rate of malignant gliomas. II. Effects of glioma mitogens and modulators of PKC. Neurosurgery. 31:1992;717-724.
32. Couldwell W.T., de Tribolet N., Antel J.P., Gauthier T., Kuppner M.C. Adhesion molecules and malignant gliomas: implications for tumorigenesis. J. Neurosurg. 76:1992;782-791.
33. Couldwell W.T., Hinton D.R., He S., Chen T.C., Sebat I., Weiss M.H., Law R.E. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 345:1994;43-46.
34. Couldwell W.T., Hinton D.R., Surnock A.A. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin. Cancer Res. 2:1996;619-622.
35. Couldwell W.T., Uhm J.H., Antel J.P., Yong V.W. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery. 29:1991;880-887.
36. de Ridder L., Calliauw L. Invasion of human brain tumors in vitro: relationship to clinical evolution. J. Neurosurg. 72:1990;589-593.
37. Dedhar S. Integrins and tumor invasion. BioEssays. 12:1990;583-590.
38. Delage S., Chastre E., Empereur S., Wicek D., Veissiere D., Capeau J., Gespach C., Cherqui G. Increased protein kinase C alpha expression in human coloic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res. 53:1993;2762-2770.
39. DiBattista J.A., Pelletier J.P., Zafarullah M., Fujimoto N., Obata K., Martel-Pelletier J. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J. Rheumatol. 43:1995;123-128.
40. Easty G.C., Easty D.M. In vivo and in vitro models of invasion. Mareel M.M., Calman K.C. Invasion Experimental and Clinical Implications. 1984;24-62 Oxford University Press, New York.
41. Eldar H., Zisman Y., Ullrich A., Livneh E. Overexpression of protein kinase C(subtype in swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J. Biol. Chem. 265:1990;13290-13296.
42. Evans, C.W. In vitro model systems for the study of tumor cell invasion and metastasis in the metastatic cell. Behav. Biochem., 1991, 293-331.
43. Furcht L.T., Skubitz A.P., Fields G.B. Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab. Invest. 70:1994;781-783.
44. Goldberg W.J., Levine K.V., Tadvalkar G., Laws E.R. Jr, Bernstein J.J. Mechanisms of C6 glioma cell and fetal astrocyte migration in hydrated collagen I gels. Brain Res. 581:1992;81-90.
45. Gopalakrishna R., Barsky S.H. Tumor promoter-induced membrane-bound kinase C regulates hematogenous metastasis. Proc. Natl. Acad. Sci. USA. 85:1988;612-616.
46. Gruber J.R., Ohno S., Niles R.M. Increased expression of protein kinase Cα plays a key role in retinoic acid-induced melanoma differentiation. J. Biol. Chem. 267:1992;13356-13360.
47. Hendrix M.J., Seftor E.A., Seftor R.E., Fidler I.J. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett. 38:1987;137-147.
48. Hochberg F.H., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 30:1980;907-911.
49. Honn K.V., Timar J., Rozhin J., Bazaz R., Sameni M., Ziegler G., Sloane B.F. A lipoxygenase metabolite, 12-S-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 214:1994;120-130.
50. Huang M., Chida K., Kamata N., Nose K., Kato M., Homma Y., Takenawa T., Kuroki T. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. J. Biol. Chem. 263:1988;17975-17980.
51. Hug H., Sarre T.F. Protein kinase C isoenzyme divergence in signal transduction. Biochem. J. 291:1993;329-343.
52. Isakov N., Gopas J. Effect of protein kinase C activating tumor promoters on metastases formation by fibrosarcoma cells. Invasion Metast. 11:1991;11-24.
53. Jaken S. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8:1996;168-173.
54. Juarez J., Clayman G., Nakajima M., Tanabe K.K., Saya H., Nicolson G.L., Boyd D. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer. 55:1993;10-18.
55. Kohn E.C., Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 55:1995;1856-1862.
56. Koochekpour S., Merzak A., Pilkington G.J. Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma lines. Eur. J. Cancer. 31:1995;375-380.
57. 2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells. Cancer Res. 49:1989;2597-2602.
58. Lamph W.W., Wamsley P., Sassone-Corsi P., Verma I.M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 334:1988;629-631.
59. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative reguration. Cell. 64:1991;327-336.
60. Liotta L.A., Kohn E. Cancer invasion and metastases. JAMA. 263:1990;1123-1126.
61. Matsumoto T., Tani E., Yamaura I., Miyaji K., Kaba K. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Neurosurgery. 36:1995;565-572.
62. Merzak A., Koocheckpour S., Pilkington G.J. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res. 54:1994;3988-3992.
63. Merzak A., Koocheckpour S., Pilkington G.J. Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro. Neurosci. Lett. 177:1994;11-16.
64. Mischak H., Goodnight J., Kolch W. Overexpression of protein kinase Cδ and ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenecity. J. Biol. Chem. 268:1993;6090-6096.
65. Misra-Press A., Fields A.P., Samols D., Goldthwait D.A. Protein kinase C isoforms in human gliablastoma cells. Glia. 6:1992;188-191.
66. Nabeshima K., Komada N., Kishi J., Koita H., Inoue T., Hayakawa T., Koono M. TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. Int. J. Cancer. 55:1993;974-981.
67. Nerlov C., Ronh P., Blasi F., Johnsen M. Essential AP1 and PEA3 binding elements in the human urokinase enhancer display cell typespecific activity. Oncogene. 5:1990;7583.
68. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications in cellular regulation. Nature. 334:1988;661-665.
69. O'Brian C.A., Liskamp R.M., Solomon D.H., Weinstein I.B. Inhibition of protein kinase C by tamoxifen. Cancer Res. 45:1985;2462-2465.
70. Pollack I.F., Randall M.S., Kristofik M.P., Kelly R.H., Selker R.G., Vertosick F.T. Jr. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res. 50:1990;7134-7138.
71. Qian F., Bajkowski A.S., Steiner D.F., Chan S.J., Frankfater A. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res. 49:1989;4870-4875.
72. Redwood S.M., Liu B.C., Weiss R.E., Hodge D.E., Droller M.J. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor. Cancer. 69:1992;1212-1219.
73. Reifenberger G., Deckert M., Wechsler W. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol. 78:1989;166-175.
74. Rempel S.A., Rosenblum M.L., Mikkelsen T., Yan P.S., Ellis K.D., Golembieski W.A., Sameni M., Rozhin J., Ziegler G., Sloane B.F. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54:1994;6027-6031.
75. Rochefort H., Capony F., Garcia M., Cathepsin D. A protease involved in breast cancer metastasis. Cancer Metast. Rev. 9:1990;321-331.
76. Ruoslahti E. Control of cell motility and tumour invasion by extracellular matrix interactions. Br. J. Cancer. 66:1992;239-242.
77. Sanz L., Berra E., Municio M.M., Dominguez I., Lozano J., Johansen T., Moscat J., Diaz-Meco M.T. Zeta PKC plays a critical role during stromelysin promoter activation by platelet-derived growth factor through a novel palindromic element. J. Biol. Chem. 269:1994;10044-10049.
78. Schwartz G.K., Jiang J., Kelsen D., Albino A.R. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J. Natl. Cancer Inst. 85:1994;402-407.
79. Schwartz G.K., Redwood S.M., Ohnuma T., Holland J.F., Droller M.J., Liu B.C. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J. Natl. Cancer Inst. 82:1990;1753-1756.
80. Shimosawa S., Hachiya T., Hagiwara M., Usuda N., Sugita K., Hidaka H. Type-specific expression of protein kinase C isozymes in CNS tumor cells. Neurosci. Lett. 108:1990;11-16.
81. Sloane B.F., Honn K.V., Sadler J.G., Turner W.A., Kimpson J.J., Taylor H. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res. 42:1982;980-986.
82. Steinsvag S.K., Laerum O.D., Bjerkvig R. Interaction between rat glioma cells and normal rat brain tissue in organ culture. J. Natl. Cancer Inst. 74:1985;1095-1099.
83. Takenaga K., Takahashi K. Effects of 12Otetradecanylphorbol 13acetate on adhesiveness and lungcolonizing ability of Lewis lung carcinoma cells. Cancer Res. 40:1986;375-380.
84. Todo T., Shitara N., Nakamura H., Takakura K., Ikeda K. Immunohistochemical demonstration of protein kinase C isozymes in human brain tumours. Neurosurgery. 108:1991;11-16.
85. Uhm J.H., Dooley N.P., Villemure J.G., Yong V.W. Glioma invasion in vitro regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metast. 14:1996;421-433.
86. Walker J.M. Gradient SDS polyacrylamide gel electroporesis. Walker J.M. Methods in Molecular Biology. 1984;57-61 Humana Press, Clifton.
87. Weinstein I.B. Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspect. 93:1991;175-179.
88. Weiss R.E., Liu B.C., Ahlering T., Dubeau L., Droller M.J. Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J. Urol. 144:1990;798-804.
89. Welch D.R., Bhuyan B.K., Liotta L.A. Experimental and clinical strategies. Welch D.R., Bhuyan B.K., Liotta L.A. Cancer Metastasis. 1986;132-137 Alan Liss, New York.
90. Xiao H., Goldthwait D.A., Mapstone T. The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J. Neurosurg. 81:1994;734-740.
91. Yamanishi D.T., Graham M., Buckmeier J.A., Meykens F.L. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis. 12:1991;105-109.
92. Yazaki T., Ahmad S., Chahlavi A., Zylber-Katz E., Dean N.M., Rabkin S.D., Martuza R.L., Glazer R.I. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase Cα phosphorothioate oligodeoxyoucleotide. Mol. Pharmacol. 50:1996;236-242.
93. Yong V.W., Dooley N.P., Noble P.G. Protein kinase C in cultured adult human oligodendrocytes: A potential role for isoform α as a mediator of process outgrowth. J. Neurosci. Res. 39:1994;83-96.
94. Zhang W., Yamada H., Sakai N., Nikawa S., Nozawa Y. Enhancement of radio-sensitivity by tamoxifen in C6 glioma cells. Neurosurgery. 31:1992;125-130.